Last reviewed · How we verify
Disease caused by Severe acute respiratory syndrome coronavirus 2
Approved treatments
- Veklury · Gilead Sciences
Remdesivir is an antiviral nucleotide analog RNA polymerase inhibitor with activity against SARS-CoV-2. - Veklury · ANRS, Emerging Infectious Diseases
- Xocova · Shionogi & Co., Ltd.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Disease caused by Severe acute respiratory syndrome coronavirus 2 patent landscape — cliff calendar, originator estates, attackable patents
- Disease caused by Severe acute respiratory syndrome coronavirus 2 treatment landscape brief
- Disease caused by Severe acute respiratory syndrome coronavirus 2 treatment updates RSS
Frequently asked questions about Disease caused by Severe acute respiratory syndrome coronavirus 2
What drugs treat Disease caused by Severe acute respiratory syndrome coronavirus 2?
Tracked treatments include Veklury, Xocova.
What is the treatment for Disease caused by Severe acute respiratory syndrome coronavirus 2?
Standard treatment for Disease caused by Severe acute respiratory syndrome coronavirus 2 includes Veklury, Xocova. See the treatment landscape page for first-line, second-line and salvage options.
Related
- Treatment landscape: Disease caused by Severe acute respiratory syndrome coronavirus 2 patent cliff · Disease caused by Severe acute respiratory syndrome coronavirus 2 CI report
- Treatment: Veklury · Gilead Sciences
- Treatment: Veklury · ANRS, Emerging Infectious Diseases
- Treatment: Xocova · Shionogi & Co., Ltd.
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing